UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Safety and pharmacokinetics of paclitaxel and the oral mTOR inhibitor everolimus in advanced solid tumours

British journal of cancer, 2009-01, Vol.100 (2), p.315-321

2009

Link zum Volltext

Verfügbarkeit prüfen

In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576

Cancer research (Chicago, Ill.), 2001-01, Vol.61 (2), p.749-758

2001

Link zum Volltext

Verfügbarkeit prüfen

The role of central 5-HT receptors in the bronchoconstriction evoked by inhaled capsaicin in anaesthetised guinea-pigs

Neuropharmacology, 1998-01, Vol.37 (2), p.243-250

1998

Link zum Volltext

Verfügbarkeit prüfen

Involvement of central 5‐HT1A receptors in the reflex activation of pulmonary vagal motoneurones by inhaled capsaicin in anaesthetized cats

British journal of pharmacology, 1996-02, Vol.117 (4), p.724-728

1996

Link zum Volltext

Verfügbarkeit prüfen

Phase I Study of the Pi3K Inhibitor Byl719, As a Single Agent in Patients with Advanced Solid Tumors (Ast)

Annals of oncology, 2014-09, Vol.25, p.iv150

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-16-14: Preliminary safety, pharmacokinetics and anti-tumor activity of BYL719, an alpha-specific PI3K inhibitor in combination with fulvestrant: Results from a phase I study

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P2-P2-16-14

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical efficacy, tolerability, and safety of SAM486A, a novel polyamine biosynthesis inhibitor, in patients with relapsed or refractory non-Hodgkin's lymphoma: Results from a Phase II multicenter study

Clinical cancer research, 2004-02, Vol.10 (4), p.1299-1305

2004

Link zum Volltext

Verfügbarkeit prüfen

Phase I and Pharmacokinetic Study of the Polyamine Synthesis Inhibitor SAM486A in Combination with 5-Fluorouracil/ Leucovorin in Metastatic Colorectal Cancer

Clinical cancer research, 2004-03, Vol.10 (6), p.1949-1955

2004

Link zum Volltext

Verfügbarkeit prüfen

Molecular pharmacodynamic (MPD) evaluation of dose and schedule of RAD001 (everolimus) in patients with operable prostate carcinoma (PC)

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.3071-3071

2005

Link zum Volltext

Verfügbarkeit prüfen

Antitumor activity of XR5944, a novel and potent topoisomerase poison

Anti-cancer drugs, 2001-04, Vol.12 (4), p.359-367

2001

Link zum Volltext

Verfügbarkeit prüfen

In vitro and in vivo characterization of XR11576, a novel, orally active, dual inhibitor of topoisomerase I and II

Anti-cancer drugs, 2002-01, Vol.13 (1), p.15-28

2002

Link zum Volltext

Verfügbarkeit prüfen

451PDPHASE I STUDY OF THE PI3Kα INHIBITOR BYL719, AS A SINGLE AGENT IN PATIENTS WITH ADVANCED SOLID TUMORS (AST)

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv150-iv150

2014

Link zum Volltext

Verfügbarkeit prüfen

359 Phase Ib and pharmacokinetic studies of Everolimus (RAD001), a novel oral mTOR-inhibitor, with paclitaxel in patients with advanced solid tumors

European journal of cancer supplements, 2004-09, Vol.2 (8), p.108-108

2004

Link zum Volltext

Verfügbarkeit prüfen

Central 5-HT1A receptors modulate reflex bronchoconstriction in guinea-pigs

Pharmacological research, 1995, Vol.31, p.273-273

1995

Link zum Volltext

Verfügbarkeit prüfen

Central 5-HT1A and 5-HT1D receptors modulate reflex bronchoconstriction in guinea-pigs

Pulmonary pharmacology (Edinburgh), 1996-10, Vol.9 (5-6), p.369-370

1996

Link zum Volltext

Verfügbarkeit prüfen

Involvement of central 5-HT sub(1A) receptors in the reflex activation of pulmonary vagal motoneurones by inhaled capsaicin in anaesthetized cats

British journal of pharmacology, 1996-01, Vol.117 (4), p.724-728

1996

Link zum Volltext

Verfügbarkeit prüfen

Algebraic Techniques for Short(er) Exact Lattice-Based Zero-Knowledge Proofs

Advances in Cryptology – CRYPTO 2019, p.176-202

Link zum Volltext

Verfügbarkeit prüfen

DualDory: Logarithmic-Verifier Linkable Ring Signatures Through Preprocessing

Computer Security – ESORICS 2022, p.427-446

Link zum Volltext

Verfügbarkeit prüfen

Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro

Angiogenesis (London), 2001, Vol.4 (4), p.269-275

2001

Link zum Volltext

Verfügbarkeit prüfen

LAFORGUE ET LE BOUDDHISME DILETTANTE

Revue d'histoire littéraire de la France, 2017-06, Vol.117 (2), p.273-282

Bootle, Sam

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT-01: BYL719, a next generation PI3K alpha specific inhibitor: Preliminary safety, PK, and efficacy results from the first-in-human study

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.CT-01-CT-01

2012

Link zum Volltext

Verfügbarkeit prüfen

Localization of bilirubin in phospholipid bilayers by parallax analysis of fluorescence quenching

Journal of lipid research, 2001-09, Vol.42 (9), p.1377-1388

2001

Link zum Volltext

Verfügbarkeit prüfen

Clinical Efficacy, Tolerability, and Safety of SAM486A, a Novel Polyamine Biosynthesis Inhibitor, in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma

Clinical cancer research, 2004-02, Vol.10 (4), p.1299-1305

2004

Link zum Volltext

Verfügbarkeit prüfen

Localization of bilirubin in phospholipid bilayers by parallax analysis of fluorescence quenching1

Journal of lipid research, 2001-09, Vol.42 (9), p.1377-1388

2001

Link zum Volltext

Verfügbarkeit prüfen

An integrated approach to assessing the farm and market level impacts of new technology adoption in Australian lamb production and marketing systems: The case of large, lean lamb

Agricultural systems, 1995, Vol.47 (2), p.175-198

1995

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(29)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Life Sciences & Biomedicine
(13)
Biological And Medical Sciences
(9)
Humans
(8)
Female
(7)
Animals
(6)
Male
(6)
Medical Sciences
(6)
Oncology
(6)
Adult
(5)
Pharmacology & Pharmacy
(5)
Aged
(4)
Middle Aged
(4)
Treatment Outcome
(4)
Antineoplastic Agents
(3)
Antineoplastic Agents - Pharmacology
(3)
Colonic Neoplasms - Drug Therapy
(3)
Dose-Response Relationship, Drug
(3)
Drug Resistance, Multiple
(3)
Drug Resistance, Neoplasm
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety and pharmacokinetics of paclitaxel and the oral mTOR inhibitor everolimus in advanced solid tumours

In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576

The role of central 5-HT receptors in the bronchoconstriction evoked by inhaled capsaicin in anaesthetised guinea-pigs

Involvement of central 5‐HT1A receptors in the reflex activation of pulmonary vagal motoneurones by inhaled capsaicin in anaesthetized cats

Phase I Study of the Pi3K Inhibitor Byl719, As a Single Agent in Patients with Advanced Solid Tumors (Ast)

Abstract P2-16-14: Preliminary safety, pharmacokinetics and anti-tumor activity of BYL719, an alpha-specific PI3K inhibitor in combination with fulvestrant: Results from a phase I study

Clinical efficacy, tolerability, and safety of SAM486A, a novel polyamine biosynthesis inhibitor, in patients with relapsed or refractory non-Hodgkin's lymphoma: Results from a Phase II multicenter study

Phase I and Pharmacokinetic Study of the Polyamine Synthesis Inhibitor SAM486A in Combination with 5-Fluorouracil/ Leucovorin in Metastatic Colorectal Cancer

Molecular pharmacodynamic (MPD) evaluation of dose and schedule of RAD001 (everolimus) in patients with operable prostate carcinoma (PC)

Antitumor activity of XR5944, a novel and potent topoisomerase poison

In vitro and in vivo characterization of XR11576, a novel, orally active, dual inhibitor of topoisomerase I and II

451PDPHASE I STUDY OF THE PI3Kα INHIBITOR BYL719, AS A SINGLE AGENT IN PATIENTS WITH ADVANCED SOLID TUMORS (AST)

359 Phase Ib and pharmacokinetic studies of Everolimus (RAD001), a novel oral mTOR-inhibitor, with paclitaxel in patients with advanced solid tumors

Central 5-HT1A receptors modulate reflex bronchoconstriction in guinea-pigs

Central 5-HT1A and 5-HT1D receptors modulate reflex bronchoconstriction in guinea-pigs

Involvement of central 5-HT sub(1A) receptors in the reflex activation of pulmonary vagal motoneurones by inhaled capsaicin in anaesthetized cats

Algebraic Techniques for Short(er) Exact Lattice-Based Zero-Knowledge Proofs

DualDory: Logarithmic-Verifier Linkable Ring Signatures Through Preprocessing

Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro

LAFORGUE ET LE BOUDDHISME DILETTANTE

Abstract CT-01: BYL719, a next generation PI3K alpha specific inhibitor: Preliminary safety, PK, and efficacy results from the first-in-human study

Localization of bilirubin in phospholipid bilayers by parallax analysis of fluorescence quenching

Clinical Efficacy, Tolerability, and Safety of SAM486A, a Novel Polyamine Biosynthesis Inhibitor, in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma

Localization of bilirubin in phospholipid bilayers by parallax analysis of fluorescence quenching1

An integrated approach to assessing the farm and market level impacts of new technology adoption in Australian lamb production and marketing systems: The case of large, lean lamb

Suchergebnisse filtern